Skip to main content

Diabetes Mellitus: Pharmacotherapy- SGLT, Centrally Acting Dopamine Agonists & Bile Acid Sequestrants!

 PHARMACOTHERAPY:

Medications classifications include:

  1.  Sulfonyl Urea's
  2. Nonsylfonylurea Secretagogues (a-Glinides)
  3. Biguanides
  4. Thiazolidinediones
  5. a-Glucosidase Inhibitors
  6. Dipeptidyl Peptidase-4 Inhibitors (Gliptins)
  7. Sodium-glucose co-transporter (SGLT) Inhibitors 
  8. Central-Acting Dopamine Agonists
  9. Bile Acid Sequestrants
  10. Insulin therapy

7.SODIUM-GLUCOSE CO-TRANPORTER (SGLT-2) INHIBITORS

The drugs approved include Canagliflozin, Dapagliflozin, Empagliflozin.

Mechanism of Action:

  • Glucose is freely filtered buy the kidney glomeruli and is reabsorbed in the proximal convoluted tubules by the action of sodium glucose co-transporters (SGLT). SGLT accounts for 90% of the glucose reabsorption and its inhibition causes glycosuria in people with diabetes, lowering plasma glucose levels.

Dose:

Canagliflozin: 100 & 300mg- 100mg daily if usual dose. 300mg daily can be used if eGFR resulting in lowering HDL. 

Dapagliflozin: 3 & 10mg- 10 mg daily. 3mg daily in hepatic failure.

Empagliflozin: 10 & 25mg- 10mg daily. 25 mg daily can be used if necessary.


8.CENTRAL ACTING DOPAMINE AGONISTS

  • A quick release formulation of a central acting dopamine agonist Bromocriptine was approved by the FDA in May 2009 for the treatment of T2DM.

Mechanism of Action:

  • The exact mechanism of action of how bromocriptine regulates glycemic control is unknown, however, data indicates that bromocriptine administered in the morning improves insulin sensitivity and this is a likely result of its effect on dopamine oscillations.

Clinical use:

  • A modest A1c reduction of 0.1%-0.4% is expected from this drug.

Adverse Effects:

  • Rhinitis
  • Dizziness
  • Asthenia
  • Headache
  • Sinusitis
  • Constipation
  • Nausea

Dose:

  • When used to treat patients with T2DM, bromocriptine should be taken 2hr after waking up in the morning with food. 
  • The initial dose is 0.8mg, titrated up weekly until a maximum dosage of 4.8mg/day is achieved.

Contraindication:

  • It is contraindicated in patients with migraine and in women who are nursing.


9.BILE ACID SEQUESTRANTS

  • Colesevelam is the only bile acid sequestrant currently approved as the adjunctive therapy to improve glycemic control in conjunction with diet, exercise and insulin or oral agents for the treatment of T2 DM.

Mechanism of action:

It acts on the intestinal lumen to bind bile acid but whether this is the drugs only action that results in plasma glucose lowering or if a secondary systemic effect to bile acid binding is unknown.

Clinical use:

  • An A1c reduction of approximately 0.4% can be expected when added to metformin, sulfonylurea or insulin. 
  • FPG is reduced about 5-10mg/dL.
  • LDL cholesterol is reduced 12-16%

Dose:

  •   Dosing for T2DM is 6*625mg tablets daily which may be split into 3 tablets twice daily.

Adverse Effects:

  • Constipation
  • Dyspepsia
  • Drug-drug interactions with Levothyroxine, Glyburide, Oral contraceptives, Phenytoin, Warfarin, Digoxin
  • Malabsorption of fat-soluble vitamins A, D, E and K 

Labels:

Comments

Post a Comment

Popular posts from this blog

Diabetes Mellitus: Types!

TYPES OF DIABETES MELLITUS 1. TYPE1 DM Type 1 DM is usually diagnosed before age 30 years, but it can develop at any age. T1DM is an autoimmune disease in which insulin producing B-cells are destroyed. The presence of Human Leucocyte Antigens (HLAs ) is associated with the development of T1DM. In addition, these individuals often develop Islet cell antibodies , Insulin Autoantibodies or Glutamic Acid decarboxylase autoantibodies . At the time of development of diagnosis of T1DM, it is usually believed that most of the patients have 80-90%loss of beta cells. The remaining beta cells function at the diagnosis creates a " HONEYMOON PERIOD" during which the blood glucose levels are easier to control, and smaller amounts of insulin are required. after this, the remaining beta cells function is completely lost, and the patients become completely deficient of insulin and hence require exogenous insulin.  2. TYPE1.5 DM:  Also referred as Latent autoimmune diabetes in Adults (LAD)
Post a Comment
Read more

Diabetes Mellitus: Pharmacotherapy- Gliptins and a-Glycoside Inhibitors!

  PHARMACOTHERAPY:  Medications classifications include:  Sulfonyl Urea's Nonsylfonylurea Secretagogues (a-Glinides) Biguanides Thiazolidinediones a-Glucosidase Inhibitors Dipeptidyl Peptidase-4 Inhibitors (Gliptins) Sodium-glucose co-transporter (SGLT) Inhibitors  Central-Acting Dopamine Agonists Bile Acid Sequestrants Insulin therapy 5. a-GLUCOSIDASE INHIBITORS Acarbose and Miglitol are a-glucosidase inhibitors currently approved in the United States. Mechanism of Action: An enzyme that is along the brush border of the intestine cells called a-glucosidase; breaks down the complex carbohydrates into simple sugars, resulting in absorption. The a-glucosidase inhibitors work by delaying the absorption of carbohydrates from the intestinal tract, which reduces the rise in postprandial glucose levels. Therapy: As a monotherapy , a-glucosidase inhibitors primarily reduce post-prandial glucose excursions.  Clinical Use: FPG concentrations have been decreased by 40-50mg/dL and A1c level
Post a Comment
Read more

GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD)!

MANAGEMENT OF GASTRO-ESOPHAGEAL REFLUX DISEASE  "GERD refers to the endoscopically determined esophagitis or endoscopy-negative reflux disease" . "GERD is the term used to describe any symptomatic clinical condition or histopathological alteration resulting from episodes of reflux of acid, pepsin and occasionally, bile into the esophagus from the stomach". Patients with uninvestigated "reflux-like" symptoms should be managed as patients with uninvestigated dyspepsia. There is currently no evidence that H.pylori should be investigated in patients with GERD. Symptoms: Heartburn is the characteristic symptom of GERD. Acid regurgitation Dysphagia Belching Upper abdominal discomfort Bloating and postprandial fullness Chest pain Hoarseness Cough Complications include: Esophageal ulceration Formation of specialized columnar-lined esophagus at the gastro-esophageal junction known as Barretts Esophagus . Mechanism of Acid Reflux: The mechanism of acid reflux is mu
Post a Comment
Read more